Rodman & Renshaw Sees 160% Upside For NeuroMetrix
June 28, 2016 at 12:04 PM EDT
Rodman & Renshaw started coverage of Neurometrix Inc (NASDAQ: NURO) with a Buy rating and a target price of $4.50, implying an upside of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.